|Articles|July 1, 2022

Top 5 Infectious Disease Stories of the Week: July 1, 2022

Here is a rundown of the most popular and significant stories we covered this past week.

Have you been too busy to catch up on the news this past week? Here is an opportunity to do so with some of the important stories we have been covering this week.

Contagion compiles 5 highlights of our coverage in infectious disease including video interviews, podcasts, and significant stories from the week ending July 1, 2022.

Here are Contagion’s highlights from the week:

1. FDA Vaccine Advisory Committee Recommends Booster Vaccines Optimized for Omicron
After an all-day meeting, the FDA’s Vaccine and Related Biological Products Advisory Committee (VRBPAC) voted 90% YES to recommend this fall’s COVID-19 booster doses target Omicron.

2. Pfizer-BioNTech Vaccine Efficacy Against Omicron in Children 5-11 Years
 In children 5-11 years old, 2 doses of the Pfizer-BioNTech COVID-19 vaccine were moderately effective against documented, symptomatic Omicron infection.

3. WHO Emergency Committee Does Not Declare Monkeypox Public Health Emergency
The World Health Organization did not declare monkeypox a global health emergency, instead calling it an “evolving health threat” that requires continued monitoring.

4. Pfizer Files FDA NDA for Paxlovid
The submission is based off both non-clinical and clinical data, including results from the phase 2/3 EPIC-HR study.

5. CDC: Listeria Outbreak With Most Living or Traveling to Florida
The federal agency has reported 1 death and 22 hospitalizations stemming back to January of 2021.


Related to this article

Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
FAQ: Ebola Prevention, Treatment and the Chances of a US Outbreak
As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.